{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:05:45Z","timestamp":1758056745720,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T00:00:00Z","timestamp":1606435200000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.encep.2019.05.008","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T08:21:18Z","timestamp":1566289278000},"page":"482-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["S\u00e9curisation de la prise en charge m\u00e9dicamenteuse des patients sous antipsychotiques\u00a0: impact de la collaboration m\u00e9dico-pharmaceutique \u00e0 la Maison d\u2019Arr\u00eat de Lyon-Corbas"],"prefix":"10.1016","volume":"45","author":[{"given":"C.","family":"Picard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Lalande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bertin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Abel-coindoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mauchauff\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Giret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Cabelguenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.encep.2019.05.008_bib0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.encep.2014.12.003","article-title":"Niveau de vigilance des psychiatres pour les facteurs de risque cardiovasculaire chez les patients schizophr\u00e8nes","volume":"41","author":"Rouillon","year":"2015","journal-title":"Encephale"},{"issue":"8","key":"10.1016\/j.encep.2019.05.008_bib0145","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.eurpsy.2015.09.029","article-title":"Troubles mentaux et mortalit\u00e9","volume":"30","author":"Saravane","year":"2015","journal-title":"Eur Psychiatry"},{"issue":"1\u00a0Suppl","key":"10.1016\/j.encep.2019.05.008_bib0150","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0013-7006(09)75531-9","article-title":"Schizophr\u00e9nie et sujets \u00e2g\u00e9s","author":"Limosin","year":"2009","journal-title":"Encephale"},{"issue":"1","key":"10.1016\/j.encep.2019.05.008_bib0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.encep.2018.07.007","article-title":"Centres Experts Schizophr\u00e9nie, un outil pour le soin et la recherche: retour sur 10\u00a0ans d\u2019exp\u00e9rience","volume":"45","author":"Sch\u00fcrhoff","year":"2019","journal-title":"Encephale"},{"issue":"3","key":"10.1016\/j.encep.2019.05.008_bib0160","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11690-013-0365-x","article-title":"Effets m\u00e9taboliques ind\u00e9sirables des antipsychotiques","volume":"8","author":"F\u00e8ve","year":"2013","journal-title":"Ob\u00e9sit\u00e9"},{"issue":"4","key":"10.1016\/j.encep.2019.05.008_bib0165","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.emcps.2005.08.001","article-title":"Modalit\u00e9s d\u2019utilisation des neuroleptiques","volume":"2","author":"Franck","year":"2005","journal-title":"EMC-psychiatr"},{"issue":"2","key":"10.1016\/j.encep.2019.05.008_bib0170","first-page":"159","article-title":"Comorbidit\u00e9s somatiques chez les patients souffrants de schizophr\u00e9nie trait\u00e9e. Recommandations actuelles","volume":"164","author":"Lefebvre","year":"2006","journal-title":"Ann Med Psychol"},{"issue":"5","key":"10.1016\/j.encep.2019.05.008_bib0175","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1192\/bjp.bp.108.052605","article-title":"Metabolic profile of antipsychotic - naive individuals with non-affective psychosis","volume":"194","author":"Fernandez-Egea","year":"2009","journal-title":"Br J Psychiatry"},{"issue":"5","key":"10.1016\/j.encep.2019.05.008_bib0180","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.encep.2007.06.009","article-title":"Surveillance cardiologiques des patients trait\u00e9s par neuroleptiques","volume":"34","author":"Frimas","year":"2008","journal-title":"Encephale"},{"issue":"1","key":"10.1016\/j.encep.2019.05.008_bib0185","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11096-016-0414-2","article-title":"Risk factors for QTc-prolongation: systematic review of the evidence","volume":"39","author":"Vandael","year":"2017","journal-title":"Int J Clin Pharm"},{"year":"2007","series-title":"Guide-Affection de longue dur\u00e9e-schizophr\u00e9nies. [Internet]","author":"Haute Autorit\u00e9 de Sant\u00e9","key":"10.1016\/j.encep.2019.05.008_bib0190"},{"key":"10.1016\/j.encep.2019.05.008_bib0195","unstructured":"ANSM. Suivi cardio-m\u00e9tabolique des patients trait\u00e9s par antipsychotiques. [Internet] afssaps\u00a0; 2010\u00a0Mars [cited 2017\u00a0Nov 22]. Available from: https:\/\/ansm.sante.fr\/var\/ansm_site\/storage\/original\/application\/6b3aa2489d62f9ee02e5e6200861b2e0.pdf."},{"issue":"4","key":"10.1016\/j.encep.2019.05.008_bib0200","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.encep.2008.10.014","article-title":"Elaboration de recommandations pour le suivi somatique des patients atteints de pathologie mentale s\u00e9v\u00e8re","volume":"35","author":"Saravane","year":"2009","journal-title":"Encephale"},{"key":"10.1016\/j.encep.2019.05.008_bib0205","unstructured":"FFP-CNP.P., Recommandation de bonne pratique en psychiatrie: Comment am\u00e9liorer la prise en charge somatique des patients ayant une pathologie psychiatrique s\u00e9v\u00e8re et chronique [Internet] FFP-CNPP; 2015\u00a0Juin [cited Feb 21] Available from: http:\/\/www.psydoc-france.fr\/conf&rm\/rpc\/Reco_Soins_Soma_Psy.pdf. 2019"},{"issue":"4","key":"10.1016\/j.encep.2019.05.008_bib0210","first-page":"293","article-title":"Recommandation de bonne pratique en pharmacie clinique. Analyse d\u2019ordonnance et niveaux d\u2019analyse pharmaceutique","volume":"47","author":"Juste","year":"2012","journal-title":"Pharm Hosp Clin"},{"issue":"2","key":"10.1016\/j.encep.2019.05.008_bib0215","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4088\/JCP.v69n0219","article-title":"Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data","volume":"69","author":"Morrato","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.encep.2019.05.008_bib0220","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.encep.2011.12.006","article-title":"Evaluation de la prescription d\u2019antipsychotiques en m\u00e9decine g\u00e9n\u00e9rale: cons\u00e9quences m\u00e9taboliques","volume":"38","author":"Gignoux-Froment","year":"2012","journal-title":"Enc\u00e9phale"},{"issue":"6","key":"10.1016\/j.encep.2019.05.008_bib0225","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10597-015-9833-0","article-title":"Antipsychotic cardiometabolic side effect monitoring in a state community mental health system","volume":"51","author":"Cotes","year":"2015","journal-title":"Community Ment Health J"},{"key":"10.1016\/j.encep.2019.05.008_bib0230","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.schres.2010.11.015","article-title":"Quality of monitoring for metabolic effects associated with second generation antipsychotics in patient with schizophrenia on public insurance","volume":"126","author":"Moeller","year":"2011","journal-title":"Schizophr Res"},{"issue":"4","key":"10.1016\/j.encep.2019.05.008_bib0235","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.encep.2014.10.001","article-title":"Intervention pharmaceutiques \u00e9mises par les pharmaciens sur les m\u00e9dicaments psychotropes","volume":"41","author":"Parent","year":"2015","journal-title":"Enc\u00e9phale"},{"issue":"2","key":"10.1016\/j.encep.2019.05.008_bib0240","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/jcpt.12368","article-title":"Persistence of metabolic monitoring for psychiatry in patients treated with second-generation antipsychotics utilizing a computer-based intervention","volume":"41","author":"Lee","year":"2016","journal-title":"J Clin Pharm Ther"},{"issue":"4","key":"10.1016\/j.encep.2019.05.008_bib0245","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/1078345809340424","article-title":"Creation of a metabolic monitoring program for second generation (atypical) antipsychotics","volume":"15","author":"Reeves","year":"2009","journal-title":"J Correct Health Care"},{"issue":"3","key":"10.1016\/j.encep.2019.05.008_bib0250","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/inm.12417","article-title":"Enhancing metabolic monitoring for children and adolescents using second-generation antipsychotics","volume":"27","author":"Coughlin","year":"2018","journal-title":"Int J Ment Health Nurs"},{"key":"10.1016\/j.encep.2019.05.008_bib0255","unstructured":"Woosley, R.L., Heise, C.W., Gallo, T., et, al., CredibleMeds: QTdrugsList [internet] AZCERT; 2019\u00a0Mar [cited Mar 29] https:\/\/crediblemeds.org\/new-drug-list\/. 2019"},{"issue":"1","key":"10.1016\/j.encep.2019.05.008_bib0260","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12888-017-1289-z","article-title":"Clinicians\u2019 adherence to clinical practice guidelines for cardiac function monitoring during antipsychotic treatment: a retrospective report on 434\u00a0patients with severe mental illness","volume":"17","author":"Manchia","year":"2017","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.encep.2019.05.008_bib0265","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/070674370805300106","article-title":"Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: a controlled study","volume":"53","author":"Jennex","year":"2008","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.encep.2019.05.008_bib0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-244X-7-28","article-title":"A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients","volume":"7","author":"Mackin","year":"2007","journal-title":"BMC Psychiatry"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700619302118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700619302118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:36:37Z","timestamp":1757957797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700619302118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0013700619302118"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2019.05.008","relation":{},"ISSN":["0013-7006"],"issn-type":[{"type":"print","value":"0013-7006"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S\u00e9curisation de la prise en charge m\u00e9dicamenteuse des patients sous antipsychotiques\u00a0: impact de la collaboration m\u00e9dico-pharmaceutique \u00e0 la Maison d\u2019Arr\u00eat de Lyon-Corbas","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2019.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}